Related Experiment Video
Updated: Aug 7, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Low levels of ventricular CSF orexin/hypocretin in advanced PD
X Drouot1, S Moutereau, J P Nguyen
1Service de Physiologie-Explorations Fonctionnelles, Unité Inserm U421-Université Paris XII, Faculté de Médecine de Créteil, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France. xavier.drouot@hmn.ap-hop-paris.fr
Abstract:
The origins of excessive daytime sleepiness in Parkinson disease (PD) are unclear. The authors hypothesize that orexin neurons, a recently identified wake promoting system, could contribute to its pathophysiology. They measured orexin-A/hypocretin-1 concentration in ventricular CSF in 19 parkinsonian patients and compared it with neurologic controls. Orexin levels were lower in patients and decreased with the severity of the disease. The authors suggest that orexin neurons contribute to daytime sleepiness in late stage PD.
Related Concept Videos
Neural Regulation
Lysosomal Hydrolases
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology

